<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tab2" content-type="sidewaystable" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>Potential antiviral drugs for COVID-19.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="2" colspan="1">Potential therapeutic agents</th>
    <th align="center" rowspan="2" colspan="1">Target of inhibition</th>
    <th align="center" rowspan="2" colspan="1">Indication/purposes</th>
    <th align="center" rowspan="2" colspan="1">Preliminary studies</th>
    <th align="center" colspan="2" rowspan="1">Application for COVID-19</th>
   </tr>
   <tr>
    <th align="center" rowspan="1" colspan="1">Case studies</th>
    <th align="center" rowspan="1" colspan="1">Remarks</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Umifenovir</td>
    <td align="center" rowspan="1" colspan="1">Entry receptor</td>
    <td align="center" rowspan="1" colspan="1">Antiviral drug on influenza; not yet tested for coronaviruses</td>
    <td align="center" rowspan="1" colspan="1">N/A</td>
    <td align="center" rowspan="1" colspan="1">Compared with favipiravir (see favipiravir)</td>
    <td align="center" rowspan="1" colspan="1">Currently being evaluated in China</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Chloroquine, hydroxychloroquine</td>
    <td align="center" rowspan="1" colspan="1">Entry receptor</td>
    <td align="center" rowspan="1" colspan="1">Antiviral drug on malaria; not yet tested for coronaviruses</td>
    <td align="center" rowspan="1" colspan="1">
     <italic>In vitro</italic> antiviral activities against 2019-nCoV on primate cells [
     <xref rid="B135" ref-type="bibr">135</xref>, 
     <xref rid="B138" ref-type="bibr">138</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">Ongoing</td>
    <td align="center" rowspan="1" colspan="1">Currently being evaluated in China and the United States</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Camostat mesylate</td>
    <td align="center" rowspan="1" colspan="1">Host protease</td>
    <td align="center" rowspan="1" colspan="1">Antiviral drug on pancreatic diseases; not yet tested for coronaviruses</td>
    <td align="center" rowspan="1" colspan="1">
     <italic>In vitro</italic> antiviral activities against 2019-nCoV in human lung cancer cells [
     <xref rid="B113" ref-type="bibr">113</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">Not known</td>
    <td align="center" rowspan="1" colspan="1">None</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Lopinavir-ritonavir</td>
    <td align="center" rowspan="1" colspan="1">Viral protease</td>
    <td align="center" rowspan="1" colspan="1">Used in combination with ribavirin for SARS and MERS</td>
    <td align="center" rowspan="1" colspan="1">N/A</td>
    <td align="center" rowspan="1" colspan="1">199 hospitalized patients, Wuhan, China (99 lopinavir+ritonavir+100 standard care) [
     <xref rid="B161" ref-type="bibr">161</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">Currently being evaluated in China and the United States. However, found to be ineffective based on preliminary findings</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Darunavir</td>
    <td align="center" rowspan="1" colspan="1">Viral protease</td>
    <td align="center" rowspan="1" colspan="1">Antiretroviral drug; not yet tested for coronaviruses</td>
    <td align="center" rowspan="1" colspan="1">N/A</td>
    <td align="center" rowspan="1" colspan="1">Not known</td>
    <td align="center" rowspan="1" colspan="1">None</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ribavirin</td>
    <td align="center" rowspan="1" colspan="1">Genome replication</td>
    <td align="center" rowspan="1" colspan="1">Used in combination with lopinavir-ritonavir for SARS and MERS</td>
    <td align="center" rowspan="1" colspan="1">N/A</td>
    <td align="center" rowspan="1" colspan="1">Not known</td>
    <td align="center" rowspan="1" colspan="1">Currently being evaluated in China</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Favipiravir</td>
    <td align="center" rowspan="1" colspan="1">Genome replication</td>
    <td align="center" rowspan="1" colspan="1">Antiviral drug on influenza; not yet tested for coronaviruses</td>
    <td align="center" rowspan="1" colspan="1">N/A</td>
    <td align="center" rowspan="1" colspan="1">240 patients in Hubei province, China (120 favipiravir+120 arbidol) (preprint) [
     <xref rid="B184" ref-type="bibr">184</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">Higher recovery rate compared to those treated with umifenovir (arbidol)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Remdesivir</td>
    <td align="center" rowspan="1" colspan="1">Genome replication</td>
    <td align="center" rowspan="1" colspan="1">The new antiviral drug initially developed for Ebola</td>
    <td align="center" rowspan="1" colspan="1">
     <italic>In vitro</italic> antiviral activities toward 2019-nCoV on primate cells [
     <xref rid="B138" ref-type="bibr">138</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">Ongoing</td>
    <td align="center" rowspan="1" colspan="1">Under clinical trials</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Carolacton</td>
    <td align="center" rowspan="1" colspan="1">Genome replication</td>
    <td align="center" rowspan="1" colspan="1">Potential antibacterial compound against biofilm formation of 
     <italic>Streptococcus mutans</italic> and growth of 
     <italic>Streptococcus pneumoniae</italic> [
     <xref rid="B192" ref-type="bibr">192</xref>, 
     <xref rid="B193" ref-type="bibr">193</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">
     <italic>In vitro</italic> antiviral activities against bat kidney cells [
     <xref rid="B190" ref-type="bibr">190</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">Not known</td>
    <td align="center" rowspan="1" colspan="1">None</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Ivermectin</td>
    <td align="center" rowspan="1" colspan="1">Genome replication</td>
    <td align="center" rowspan="1" colspan="1">Antiparasitic drug (broad-spectrum).</td>
    <td align="center" rowspan="1" colspan="1">
     <italic>In vitro</italic> antiviral activities against 2019-nCoV on primate cells [
     <xref rid="B197" ref-type="bibr">197</xref>]
    </td>
    <td align="center" rowspan="1" colspan="1">Not known</td>
    <td align="center" rowspan="1" colspan="1">None</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>N/A: not available. Note: “coronaviruses” only target SARS-CoV and MERS-CoV.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
